Arbitrarily Primed-PCR and Related DNA Methylation Methodologies

Miguel A. Peinado; Jordi Frigola; Maria F. Paz; Manel Esteller

doi:10.1201/9780203487013.ch7

Related publications

Article2006

Determination of genomic damage in neuroblastic tumors by arbitrarily primed PCR: MYCN amplification as a marker for genomic instability in neuroblastomas

Jorge Muñoz, Elisenda Vendrell, Gemma Aiza, Manuel Nistal, Ángel Pestaña, aaa bbb, Javier S. Castresana

Book2004

Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma

Jasper Wouters, Miguel Vizoso, Anna Martínez‐Cardús, F. Javier Carmona, Olivier Govaere, Teresa Laguna, Jesuchristopher Joseph, Peter Dynoodt, Claudia Aura, Mona Foth, Roy H. E. Cloots, Karin van den Hurk, Balázs Bálint, Ian Murphy, Enda McDermott, Kieran Sheahan, Karin Jirström, Björn Nodin, Girish Mallya-Udupi, Joost J. van den Oord, William M. Gallagher, Manel Esteller

Chapter in a book2008

Epigenetics and Cancer DNA Methylation

Santiago Ropero, Manel Esteller

Arbitrarily Primed-PCR and Related DNA Methylation Methodologies

Discussion(0)

Related publications

Determination of genomic damage in neuroblastic tumors by arbitrarily primed PCR: MYCN amplification as a marker for genomic instability in neuroblastomas

DNA Methylation

DNA Methylation and Cancer

Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma

Epigenetics and Cancer DNA Methylation